Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Apr;31(2):138-139.
doi: 10.1177/0897190017734429. Epub 2017 Oct 3.

RE: Praluent (Alirocumab)-Induced Renal Injury

Affiliations
Comment

RE: Praluent (Alirocumab)-Induced Renal Injury

Robert S Rosenson et al. J Pharm Pract. 2018 Apr.
No abstract available

Keywords: acute renal injury; alirocumab; rosuvastatin.

PubMed Disclaimer

Comment on

  • Praluent (Alirocumab)-Induced Renal Injury.
    Jhaveri KD, Barta VS, Pullman J. Jhaveri KD, et al. J Pharm Pract. 2017 Feb;30(1):7-8. doi: 10.1177/0897190016683304. Epub 2016 Dec 14. J Pharm Pract. 2017. PMID: 28093956 No abstract available.

References

    1. Jhaveri KD, Barta VS, Pullman J. Praluent (alirocumab)-induced renal injury. J Pharm Pract. 2017;30(1):7–8. - PubMed
    1. CRESTOR (rosuvastatin calcium) [package insert]. AstraZeneca Pharmaceuticals LP. https://www.azpicentral.com/crestor/crestor.pdf#page=1. Accessed May 5, 2017.
    1. Ward FL, Bargman JM, McQuillan RF. Renal tubular toxicity associated with rosuvastatin therapy. Am J Kidney Dis. 2017;69(3):473–476. - PubMed
    1. Annigeri RA, Mani RM. Acute interstitial nephritis due to statin and its class effect Indian J Nephrol. 2015;25(1):54–56. - PMC - PubMed
    1. Lomdrino F, Zattera T, Falqui V, et al. Rosuvastatin-induced acute interstitial nephritis. Case Rep Nephrol Urol. 2013;3(1):87–90. - PMC - PubMed